Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

New tools for studying microglia in the mouse and human CNS.
Symptomatic treatment and management of multiple sclerosis.
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Alemtuzumab in the treatment of multiple sclerosis.
Defining functional changes in the brain caused by targeted stereotaxic radiosurgery.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Mesenchymal stem cells inhibit lipopolysaccharide-induced inflammatory responses of BV2 microglial cells through TSG-6.
A pilot study on factors involved with work participation in the early stages of multiple sclerosis.
The Roles of Vitamin D and Its Analogs in Inflammatory Diseases.
Reply to Letter to Editor - Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma:Should it be termed paraneoplastic?
Heatlh Care Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis Taking Once Daily Teriflunomide Tablets in the United States.
Relation of Demographics and Reported Symptoms and Medication Use in Persons with Multiple Sclerosis.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Diagnoses in Pediatric Patients With Magnetic Resonance Imaging (MRI) Lesions Suspicious for Demyelination.
Fatigue induced changes to kinematic and kinetic gait parameters following six minutes of walking in people with multiple sclerosis.
Pelvic floor disorders and multiple sclerosis: are patients satisfied with their care?
B cells in MS and NMO: pathogenesis and therapy.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Local overexpression of interleukin-11 in the central nervous system limits demyelination and enhances remyelination.
The role of dendritic cells in autoimmunity.

Pages